DEC1 (P = 0.044, Figure 5(b)) and DEC2 (P = 0.00023, Figure 5(d)) alteration was significantly correlated with worse OS of BC patients, while these alterations have no relation with RFS (Figures 5(c) and 5(e)). This evidence concerns the gene BHLHE41 and breast cancer.